22NW, LP

Position in NKTR — Nektar Therapeutics

CIK 1694297 SEATTLE, WA

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$19,624,638

-$601,586 QoQ

Shares Held

281,115

0.0% QoQ

Ownership

0.823%

of shares outstanding

% of Portfolio

18.75%

of 13F equity value

Holder Rank

#27

of 240 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

22NW, LP holds $35,373,962 across 5 Biotechnology names. NKTR ranks #1 (55.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NKTR	Nektar Therapeutics This page	281,115	$19,624,638
2	RGNX	REGENXBIO Inc.	492,759	$5,903,252
3	RZLT	Rezolute, Inc.	820,653	$4,267,395
4	MLYS	Mineralys Therapeutics, Inc.	113,840	$3,071,403
5	ELDN	Eledon Pharmaceuticals, Inc.	636,364	$2,507,274

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,624,638	281,115	0.0%	Shares	Sole	2026-08-14
2026-03-31	$20,226,224	281,115	-15.1%	Shares	Sole	2026-05-15
2025-12-31	$13,999,542	331,115	0.0%	Shares	Sole	2026-02-13
2025-09-30	$18,840,443	331,115	+126.6%	Shares	Sole	2025-11-14
2025-06-30	$3,775,611	146,115	-93.3%	Shares	Sole	2025-08-14
2025-03-31	$1,490,390	2,191,750	0.0%	Shares	Sole	2025-05-14
2024-12-31	$2,038,327	2,191,750	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.